Heart transplantation using bivalirudin as anticoagulant.
We present the case of a man with heparin-induced thrombocytopenia (HIT) and acute idiopathic decompensated cardiomyopathy who underwent successful heart transplantation with the use of bivalirudin as anticoagulant.
Simsir
Sinan A
SA
Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. Sinan.simsir@cshs.org
Schwarz
Ernst R
ER
Czer
Lawrence S C
LS
Hamburg
Solomon I
SI
D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001804:Blood Transfusion, Autologous; D009202:Cardiomyopathies / Q000601:surgery*; D002315:Cardiopulmonary Bypass; D016027:Heart Transplantation; D006493:Heparin / Q000009:adverse effects; D006629:Hirudins; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D000925:Anticoagulants; D006629:Hirudins; D007166:Immunosuppressive Agents; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; C074619:bivalirudin